Predictors of immunotherapy benefit in Merkel cell carcinoma

Merkel cell carcinoma is a rare cancer for which immune checkpoint blockade is standard-of-care for recurrent/metastatic disease. However, not all patients benefit from immunotherapy. A greater understanding of molecular mechanisms and predictive biomarkers are unmet needs. We retrospectively analyz...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Kacew, Alec J., Dharaneeswaran, Harita, Starrett, Gabriel J., Thakuria, Manisha, LeBoeuf, Nicole R., Silk, Ann W., DeCaprio, James A., Hanna, Glenn J.
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2020
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720777/
https://ncbi.nlm.nih.gov/pubmed/33315984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27823
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker